ENTITY

Race Oncology (RAC AU)

4
Analysis
Health Care • Australia
Race Oncology Limited operates as a specialty pharmaceutical company. The Company focuses on rediscovering and bringing to market the cancer chemotherapy agent, Bisantrene.
more
Exchange Announcement • 12 Oct 2026 05:51

HARNESS-1 First Cohort Cleared

Exchange Announcement • 07 Oct 2026 05:54

Racura Presents CPACS Data at GCOS 2026

Exchange Announcement • 05 Oct 2026 05:36

Date of AGM & Closing Date for Director Nominations

Exchange Announcement • 29 Sep 2026 15:24

Appendix 3Y - Dr Daniel Tillett

Exchange Announcement • 23 Sep 2026 06:39

Appendix 3Y - Dr Daniel Tillett

x